(OR 1.92, 95% CI 1.26 to 2.93). Studies were clustered by intervention strategy and intensity of the intervention. Clustering reduced heterogeneity, although many trials used more than one type of intervention. The ORs for different strategies were similar (behavioural therapies OR 1.69, 95% CI 1.33 to 2.14; telephone support OR 1.58, 95% CI 1.28 to 1.97; self-help OR 1.48, 95% CI 1.11 to 1.96). More intense interventions showed increased quit rates (OR 1.98, 95% CI 1.49 to 2.65) whereas brief interventions did not appear effective (OR 0.92, 95% CI 0.70 to 1.22). Two trials had longer term follow-up, and did not show any benefits after 5 years.
Authors' conclusions
Psychosocial smoking cessation interventions are effective in promoting abstinence at 1 year, provided they are of sufficient duration. Further studies, with longer follow-up, should compare different psychosocial intervention strategies, or the addition of a psychosocial intervention strategy to pharmacological therapy (e.g. nicotine replacement therapy) compared with pharmacological treatment alone.
P L A I N L A N G U A G E S U M M A R Y
Psychosocial smoking cessation interventions such as behavioural counselling, telephone support and self-help interventions are effective in helping people with coronary heart disease stop smoking
Smoking is a risk factor for coronary heart disease and stopping smoking lowers that risk. Psychosocial smoking cessation interventions such as behavioural therapy, telephone support and self-help materials are effective in helping coronary heart disease patients to stop smoking, if they are provided for over 1month. We found evidence that psychosocial interventions increased quit rates after 6 months. Most trials used a mixture of different intervention strategies, therefore no single strategy showed superior efficacy.
B A C K G R O U N D
Smoking is a major risk factor for coronary heart disease (CHD). Compared to non-smokers the odds ratio (OR) for myocardial infarction is about 2.5, and for cardiovascular disorders overall the OR is about 2 (Cook 1986; Jacobs 1999; Kawachi 1994; Keil 1998; Njolstad 1996; Nyboe 1991; Prescott 1998; Shaper 1985; Tunstall-Pedoe 1997; Willett 1987; Woodward 1999) . Furthermore after a cardiac event smokers are two times more likely to get restenosis or to die from a cardiovascular disease (Cullen 1997; Fulton 1997; Kawachi 1993; Kawachi 1994; Kuller 1991; Luoto 1998; Tverdal 1993; Willett 1987) . A recent systematic review in patients with CHD estimated a reduction in mortality risk of 36% in 3-5 years after quitting smoking (Critchley 2003) . Nonfatal myocardial infarction also occurs less often in smokers who quit after their first cardiac event (OR 0.62, 95% CI 0.46 to 0.83) (Barth 2007) . However, many smokers do not quit, even after a CHD diagnosis (Critchley 2003) , and it is critical to summarise available evidence regarding the effectiveness of different intervention strategies for smoking cessation in this patient group.
Several intervention strategies in healthy people have shown encouraging results in systematic reviews. Simple, brief advice from a physician to quit can increase odds of quitting by over 70% (OR 1.74, 95% CI 1.48 to 2.05) (Lancaster 2004) compared with no intervention. Group behaviour therapy has been shown to double success (OR 1.97, 95% CI 1.57 to 2.48) (Stead 2005) compared with self-help interventions and is more effective than no intervention. One systematic review found that more intense interventions did not improve abstinence rates (Lancaster 2005a), however, another review found that telephone counselling was more effective than less intense interventions such as self-help (Stead 2006) . Self-help interventions may increase quit rates compared with no intervention but the effect is likely to be small (Lancaster 2005b) , and there is no evidence they have any additional effects in combination with counselling.
Rigotti has demonstrated the efficacy of smoking cessation interventions for hospitalised patients and stressed the importance of at least one follow-up contact to maintain abstinence (Rigotti 2007) . Another review showed that nursing interventions resulted in improved abstinence rates compared with no intervention (Rice 2004) , and showed comparable results in hospitalized and healthy people. These various treatment strategies can be summarised as psychosocial interventions and can be differentiated from psychopharmacological or substance replacement treatment strate-gies (e.g. antidepressants, nicotine replacement). A recent review in patients with chronic obstructive pulmonary disorders did not find a beneficial effect of psychosocial interventions on smoking abstinence, but few studies were included (van der Meer 2001) . A recent review of smoking cessation interventions in CHD patients did not find any benefits. However, this review included only 12 studies, which had been previously included in published systematic reviews (Wiggers 2003) . Although both psychosocial (n = 10) and pharmacological interventions (n = 2) were included, literature searching was not comprehensive. Integration of the studies was descriptive simply counting positive and negative results and the review was unable to assess possible dose-response relationships or influence of study quality. For cardiac patients, psychosocial interventions to quit smoking are recommended along with nicotine replacement therapies and bupropion (ACC/AHA 2002; DeBacker 2003; Ockene 1997 ). Yet, there is no clear evidence that psychosocial interventions in patients with CHD are efficacious, whether more intense interventions improve quit rates, or which components of intervention programs result in better abstinence rates.
O B J E C T I V E S
This review aimed to evaluate psychosocial intervention strategies for smoking cessation in patients with coronary heart disease, with four specific objectives.
1. To examine the efficacy of psychosocial interventions for smoking cessation in patients with coronary heart disease in short term (6 to 12 month follow-up) and long term (more than 12 months).
2. To compare different psychosocial intervention types (e.g. telephone support) to stop smoking in patients with coronary heart disease.
3. To assess the dose-response relationship: Are brief interventions as effective as more intense interventions? 4. To examine methodological criteria which may moderate the efficacy of smoking cessation interventions in patients with coronary heart disease (validation versus self-report of abstinence).
M E T H O D S
Criteria for considering studies for this review
Types of studies
We included randomised controlled trials studying the efficacy of psychosocial interventions for smoking cessation in CHD patients with an assessment of study outcome at least 6 months after baseline assessment of smoking status. Acceptable study designs were: a) psychosocial interventions to no such interventions; b) psychosocial interventions to other psychosocial interventions; and c) psychosocial interventions to the same psychosocial interventions of different intensity.
Types of participants
Patients with CHD -myocardial infarction, coronary artery bypass surgery, percutaneous transluminal coronary angioplasty (International Classification of Diseases 9 codes 410-414). Studies including patients with other diseases were accepted, provided at least 80% of patients had CHD. CHD patients with other comorbidities were included if the diagnosis of CHD was proven. Patients had to be smokers at baseline. Initial smoking status was assessed either by self-report or by additional validation measures. Hospital populations with mixed somatic events (for example pulmonary diseases and cancer) were excluded. Trials were also excluded if there was not sufficient information available about the patient's somatic diagnoses.
Types of interventions
The psychosocial intervention could be provided in two ways; either as a separate psychosocial intervention with a main focus on smoking cessation or as a part of a more comprehensive cardiac rehabilitation programme addressing also other risk factors also (such as diet). Any psychosocial intervention with the goal to change smoking behaviour in CHD patients was of interest. If the intervention strategy was solely based on a pharmacological or a nicotine replacement approach, the study was excluded. Interventions could be delivered initially during hospital admission or after hospital admission to ex-patients. The interventions may be provided in group or individual settings. Interventions that incorporated counselling, support and advice, with or without provision of written materials were included.
Types of outcome measures
Abstinence by self-report or validated (e.g. carbon monoxide) measurement at a minimum of 6 months. The outcome is dichotomous (abstinent versus smoking). We did not extract data on the number of cigarettes smoked per day, as there is little evidence that smoking reduction alters the risk of future cardiac events or mortality.
We searched the Cochrane Central Register of Controlled Trials (CENTRAL) on The Cochrane Library (issue 2, 2003) , EMBASE (until 1998 (until ), MEDLINE (1966 (until -2003 , PsycINFO (until week 34, 2003) , PSYNDEX (1977 -June 2003 . No limitations were set to randomised controlled trials. The search strategy for CENTRAL on The Cochrane Library is shown below, search strategies for other databases are in additional tables 1 to 4. #1 HEART DISEASES (exp MeSH) #2 CORONARY ARTERY BYPASS (exp MeSH) #3 angina* #4 cabg #5 (coronary near bypass*) #6 (coronary near disease*) #7 MYOCARDIAL INFARCTION (exp MeSH) #8 (myocard* near infarct*) #9 (heart near infarct*) #10 chd #11 (heart next disease*) #12 (cardiac next disease*) #13 acs #14 ami #15 (cardiac next inpatient*) #16 (cardiac next patient*) #17 (heart next patient*) #18 (heart next inpatient*) #19 (#1 or #2 or #3 or #4 or #5 or #6 or #7 or #8 or #9) #20 (#10 or #11 or #12 or #13 or #14 or #15 or #16 or #17 or #18) #21 (#19 or #20) #22 SMOKING CESSATION (exp MeSH) #23 (smoking near cessation) #24 (smoking near cease*) #25 (smoking near quit*) #26 antismoking #27 (anti next smoking) #28 (smoking near giv*) #29 (smoking near stop*) #30 (#22 or #23 or #24 or #25 or #26 or #27 or #28 or #29) #31 (#21 and #30) Additionally we searched all databases on The Cochrane Library for reviews on smoking cessation Handsearching We searched for trials included in other reviews (Lancaster 2005a; Rigotti 2007; Stead 2005; Stead 2006; Wiggers 2003) and handsearched relevant journals from 1998 to 2003 (Annals of Internal Medicine, Archives of Internal Medicine, British Medical Journal, Psychology and Health, Health Psychology, Tobacco Control). Additionally we looked through the reference lists of the initially identified trials. We asked experts from the German Statusconference on Psychocardiology for information on other trials (see http://portal.uni-freiburg.de/psychokardio/). We did not search for ongoing studies, abstracts, and unpublished studies.
Data collection and analysis
Data extraction and coding Data were independently extracted by two people (JBA and Corina Güthlin). Data on setting, CHD diagnosis or procedure, number of subjects, sex, age, and length of follow up were extracted. Five types of interventions were coded; behavioural therapeutic approaches (BT); phone support (Ph); additional self-help intervention (SH); multi-risk factor interventions (MR); specific interventions for smoking cessation (see Charactersitics of included studies table).
Treatment duration
We assessed duration of treatment as in another review (Rigotti 2007) and coded this as follows: 1) Single initial contact lasting <= 1 hour, no follow-up support; 2) One or more contacts in total > 1 hour, no follow-up support; 3) Any initial contact plus follow-up <=1 month; 4) Any initial contact plus follow-up > 1 month and <= 6 month; and 5) Any initial contact plus follow-up > 6 month.
Methodological quality
We coded biochemical validation of smoking status as 0=no and 1=yes; this validated assessment of abstinence was a very relevant methodological aspect of included studies. Quality of randomisation and allocation concealment was not coded because of lack of data in most of the trials.
Data analysis
We analysed data on both an intention-to-treat (ITT) and a followup basis. A conservative model classified persons without information about smoking status at follow-up as smokers (ITT analysis). A second model included only participants with follow-up information on smoking status. The latter model results in higher rates of abstinence in experimental and control group (termed 'optimistic model'). We present data of the conservative analysis (ITT) in preference, and only used data from the optimistic model if the ITT analysis was not possible. As a sensitivity analysis, we performed meta-analysis only including those trials where we could calculate the more conservative ITT analysis. We performed three sub-group analyses:
• Trials with validated smoking status at follow-up were compared to non-validated trials.
• Trials grouped by type of intervention.
• Trials with a treatment duration of less than 1 month versus studies with an intervention of 1 month or more.
Odds ratios with 95% confidence intervals were calculated for the pooled estimates. An OR > 1 indicates superiority of the intervention group over usual care and vice versa. Heterogeneity was assessed by examining forest plots of trials, by calculating chi squared heterogeneity test, and I² statistics. The chi squared value tests for statistically significant heterogeneity between trials; higher I² values indicate greater variability between trials than would be expected by chance alone (range 0-100%) (Higgins 2003) . A random-effects model for pooling the studies was employed because of expected heterogeneity in the primary studies (DerSimonian and Laird method) (Deeks 1999). Significant chi squared values indicate heterogeneity and therefore the pooled effect sizes must be interpreted with caution.
R E S U L T S Description of studies
See: Characteristics of included studies; Characteristics of excluded studies. The combination of the hits in the databases searched and additional citations found by scanning references in relevant Cochrane Reviews, other meta-analyses, and journals resulted in 2012 hits. After exclusions on the basis of title and abstract, 520 papers were assessed for inclusion. Of these only 241 studied an intervention for smoking cessation in cardiac patients. First we excluded all studies without a randomised controlled design (n = 145). For the exclusion of other non-relevant studies (n=71) the reason for exclusion is detailed in the characteristics of excluded studies table. A further three studies were excluded using post hoc exclusion criteria. Feeney 2001 had a drop out > 50% of randomised patients (OR 48.17 95% CI 6.42 to 361.51); Lisspers 1999 was excluded because assessment of smoking status was made after cardiac procedure had been performed, which risks confounding non-smokers with those who quit around the time of the procedure (OR 24.20, 95% CI 0.93 to 629.32); and Mitsibounas 1992 reported a statistically significant difference in patient characteristics (age/sex) between the intervention and control groups at baseline (OR 16.00, 95% CI 2.73 to 93.62). Four papers are awaiting assessment as we could not access the papers (Becker 2003; Boulay 2001; EnriquezPuga 2001; Puente-Silva 1989) . The remaining 18 reports of 16 trials were included in the review (Allen 1996; Burt 1974; Carlsson 1997; CASIS 1992; DeBusk 1994; Dornelas 2000; Hajek 2002; Heller 1993; Ortigosa 2000; Quist-Paulsen 2003; Reid 2003; Rigotti 1994; Sivarajan 1983; Taylor 1990; van Elderen (group) ; van Elderen (phone)). Seven studies were carried out in Europe (1 Sweden, 2 United Kingdom, 2 Netherlands, 1 Norway, 1 Spain), seven were from the USA, one from Australia and one from Canada. The papers were mainly published in English (15), one was written in Spanish (Ortigosa 2000) . All trials compared a specific smoking cessation intervention with a usual care condition, had comparable groups at study entry, had lower than 50% drop out rates and assessed smoking status before a cardiac event or procedure. 1323 patients were randomised to the usual care group and 1354 received a special psychosocial intervention. As expected, 70 to 90% of the patients were male, mean age was relatively young, 50 to 60 years.The patients suffered predominantly from myocardial infarction or had invasive interventions (bypass surgery, stent). The intervention strategies employed were behavioural therapeutic interventions (10 studies), and self-help programmes (11 studies). Additional phone support was provided in 11 trials. Nine studies reported interventions aimed specifically at smoking cessation, seven studies employed multi-risk strategies. Behavioural therapeutic interventions were either provided in a group setting or as individual counselling. The aim was to identify cues related to smoking, or more generally stress reduction and relaxation techniques. Other components included preparation for relapse or specific motivational techniques based on the transtheoretical model (Prochaska 1986) or the strategy of motivational interviewing (Rollnick 1997). Self-help interventions consisted of information booklets, audio-or videotapes. Information booklets which simply described risk factors were not considered self-help interventions. No studies were available for the comparison of different psychosocial interventions or of psychosocial intervention with different intensity.
Risk of bias in included studies
All studies assessed abstinence 12 months after the initial intervention, except two (Heller 1993; Sivarajan 1983) , which assessed abstinence after 6 months. Two trials also provided data on a longterm follow up after 5 years (CASIS 1992; Rigotti 1994) . Seven of the 16 trials validated self-reported abstinence. In five trials data for the 'optimistic model' was reported (n=462), 11 trials provided sufficient data for an ITT analysis (n=2215). Unfortunately, it was impossible to extract detailed information on the randomisation procedure from most of the trials. Only four trials used adequate allocation concealment (Allen 1996; Dornelas 2000; Hajek 2002; Reid 2003) .
Effects of interventions
Psychosocial smoking cessation interventions were effective in achieving smoking abstinence in CHD patients, compared with usual care. In all trials, patients receiving the specific psychosocial intervention had more than a 60% higher odds of quitting (OR 1.66, 95% CI 1.25 to 2.22). There was considerable heterogeneity between individual studies (chi² 42.68; df 15, P < 0.0002, I 2 64.9%) (comparison 01 01). Therefore the overall result has to be interpreted with caution. There were considerable differences between trials in the proportion of abstinent patients at follow-up: Taylor 1988 achieved 70% abstinence in the intervention group but Ortigosa 2000 report the same number of patients abstinent without intervention. Hajek 2002 report the lowest abstinence rates in the patients receiving psychosocial intervention (39%) and Carlsson 1997 report the lowest values for control group patients (25%).
The pooled ORs suggest that psychosocial interventions can greatly increase odds of quitting compared with usual care, but the heterogeneity in the results needed further exploration. The quality of the trials may partly explain this heterogeneity. Allocation concealment has been shown empirically to influence trial results (Jüni 2001) . Few studies reported adequate allocation concealment. We pooled results for these studies, but results of the combined effect measure must be interpreted with caution, due to the limited statistical power (Allen 1996; Dornelas 2000; Hajek 2002; Reid 2003) . The non-significant OR of trials using adequate allocation concealment was 1.10 (95% CI 0.75 to 1.60). The largest trial with adequate allocation concealment was also a brief intervention (Hajek 2002), which we found not to be effective (comparison 01 02). The pooled OR for allocation concealed trials appears lower than for all trials, but due to limited number of studies it is impossible to assess whether this is due to higher quality (allocation concealment), or the brevity of the intervention. Sensitivity analysis of only trials using ITT analysis showed less benefit than all trials combined, but remained clinical important (nearly a 50% increase in odds of quitting) and statistically significant (OR 1.47, 95% CI 1.10 to 1.96) but considerable heterogeneity remained (chi² 25.27, df 10, P < 0.005, I 2 60.4%) (comparison 01 03).
Sub-group analyses Trials validating smoking status
Trials which validated self-reported smoking status showed lower quit rates than trials where measurement was not validated. If trials with validated abstinence are pooled, the OR falls from 1.92 (95% CI 1.26 to 2.93) for non-validated trials to 1.44 (95% CI 0.99 to 2.11) for validated measures (comparison 02 01).
Types of intervention
We found no clear evidence that any treatment strategy was more efficacious than others, but heterogeneity was reduced within the intervention cluster. Behavioral therapeutic interventions showed a significant effect on abstinence (OR 1.69, 95% CI 1.33 to 2.14) with lower heterogeneity (I² 23.5%) (comparison 03 01). Telephone support was also effective (OR 1.58, 95% CI 1.28 to 1.97) and trials reasonably consistent (I² 9.9%) (comparison 03 02). However, as most behavioural therapy trials also used telephone support as an intervention strategy, it is difficult to separate the effects of these two types of interventions. Two trials used solely a behavioural therapeutic approach without additional phone contacts (Sivarajan 1983; van Elderen (group)). One trial used telephone support without behavioural therapeutic techniques (Ortigosa 2000) . Interventions using self-help materials showed comparable effectiveness (OR 1.48, 95% CI 1.11 to 1.96) (comparison 03 03). Stratification of trials using self-help materials reduced heterogeneity only slightly (I 2 56.2%). We also considered the specificity of the intervention (smoking cessation alone compared with a multi-risk factor intervention). No difference was found between multi-risk factor interventions (OR 1.73, 95% CI 1.27 to 2.35) and specific cessation intervention (OR 1.63, 95% CI 1.08 to 2.46) (comparison 03 04). While the heterogeneity in specific intervention trials increased (I 2 77.8%) the results of multi-risk factor intervention trials were statistically homogenous (I 2 0%).
Duration of the intervention
We found clear evidence that brief interventions (i.e. no followup contact or within 4 weeks after initial intervention) were not effective (Hajek 2002; Heller 1993; Ortigosa 2000; Rigotti 1994 ) (OR 0.92, 95% CI 0.70 to 1.22, I² 0%) (comparison 04 01). When CHD patients were treated with interventions including follow-up contacts after the initial period of 1 month, the odds of quitting increased substantially (OR 1.98, 95% CI 1.49 to 2.65, I² 50.3%) (comparison 04 01). There was less heterogeneity between trial results when clustered by intensity of the intervention.
Long-term follow-up
We found no evidence for efficacy of smoking cessation interventions in the long-term. Due to high drop-out rates after 5 years, an analysis for people available at follow-up and an ITT analysis were performed. Neither the optimistic model (OR 1.32, 95% CI 0.78 to 2.24) nor the ITT analysis (OR 1.23, 95% CI 0.79 to 1.93) showed superior efficacy to a control group (comparisons 05 01 and 05 02, respectively). A potential problem with all systematic reviews is publication bias. Our literature search was comprehensive, prepared and partly carried out by the Cochrane Heart Group (UK). Additionally, we investigated publication bias using a funnel plot. The results appear reasonably symmetric which is an indicator of a publication of the studies independent of the study result ( Figure 1 ). There may be a slight tendency for larger trials to show smaller benefits; but larger studies may have interventions with shorter duration and hence smaller effect sizes. 
D I S C U S S I O N
We found support for the efficacy of smoking cessation interventions with more than 1 month duration, but brief interventions without some follow-up contact were not effective. We were unable to determine the minimum number of contacts needed. More detailed conclusions about effective intervention strategies are obscured by the fact that a mixture of different intervention measures were included in many trials. Interventions using telephone support, behavioural therapies, and self-help were all effective. Some interventions focussed only on smoking cessation, but others addressed smoking as part of a multiple risk factor intervention programme (generally a 'cardiac rehabilitation programme'). There was no difference in the odds of quitting for multiple risk factor cardiac rehabilitation programmes, compared with interventions focussing only on smoking cessation. 'Cardiac rehabilitation' programmes may vary in their components, but generally include a graded exercise programme and may also include advice and support from a range of health professionals (such as dieticians, behavioural change specialists etc). It is difficult to distinguish between the effects of the smoking cessation component of these programmes, and the general support and encouragement that may be given by other health professionals. Some trials employ nicotine replacement therapy (NRT) as additional cessation strategies, which we could not control for. In one trial, more patients in the psychosocial intervention group received NRT compared to the usual care group (DeBusk 1994). Other trials did not report use of NRT.
Our findings are contrary to a recently published review on smoking cessation interventions in CHD patients which found no benefits (Wiggers 2003) . The difference may be due to more comprehensive literature searching in our review, whereas Wiggers et al aggregated 12 primary studies listed in already existing Cochrane reviews. Another difference is the methodology of the reviews. Wiggers et al counted 'positive' and 'negative' results, whereas we performed a meta-analytic pooling. The important advantage of a meta-analytic approach is the weighting of studies by sample size and event rate.
One possible threat to our results might be methodological flaws in the primary studies. Validation of abstinence was reported in primary studies, and associated with lower efficacy. The OR of quitting in validated trials was only of borderline statistical significance; however these validated trials also included many with only a brief intervention. Despite the high validity of self reported smoking status in the general population (Patrick 1994) the validation of smoking status should be recommended in efficacy trials with coronary heart disease patients (Woodward 1992).
A U T H O R S ' C O N C L U S I O N S Implications for practice
After a cardiac event about 30% to 50% of smokers with CHD quit without professional help. Additional psychosocial interventions show a superior quitting rate compared to standard care. Interventions for smoking cessation in CHD patients should last for more than 1 month. Brief interventions may not be effective. The overall effect of psychosocial smoking cessation interventions in CHD patients can be expressed by the number needed to treat statistics with a figure of 9.7. This means about 10 patients had to be treated for one person to be abstinent from tobacco after 1 year.
Implications for research
Trial procedures and quality should be described in more detail, according to CONSORT guidelines (Begg 1996) . Also more details on the duration and intensity of the intervention (total duration, number of sessions, numbers of pages in leaflets etc) are needed. The validation of smoking status was not a standard procedure in the trials as only seven described using any measure of biochemical validation. Further trials should validate smoking status objectively.
Studies comparing different psychosocial interventions or psychosocial intervention of different intensity are lacking. Hence future research should focus on the comparison of different smoking cessation strategies in CHD patients (Schmitz 1999) . It is still unclear whether individual counseling or group counseling are more beneficial in CHD patients. Also recent results of reviews show limited effects of stage based smoking cessation interventions ( Riemsma 2003; vanSluis 2004) . More detailed studies will be useful to identify components of successful intervention strategies. This approach will require fewer studies but with larger sample sizes to demonstrate relatively small, but clinically important differences between strategies. Future trials should compare the additional benefits of combining NRT and psychosocial rehabilitation, compared with NRT or psychosocial interventions alone.
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C H A R A C T E R I S T I C S O F S T U D I E S Characteristics of included studies [ordered by study ID]
Allen 1996
Methods OM 
Risk of bias
Item Authors' judgement Description
Allocation concealment? Unclear B -Unclear OM = optimistic model; ITT = intent to treat analysis; CABG = coronary artery bypass surgery; CAD = coronary artery disease; AMI = acute myocardial infarction; CG = control group; IG = experimental intervention group; GP = general practitioner Duration of treatment is coded as follows (intensity): coding 1: single initial contact lasting <= 1 hour, no follow-up support coding 2: one or more contacts in total > 1 hour, no follow-up support coding 3: any initial contact plus follow-up <=1 month coding 4: any initial contact plus follow-up > 1 month and <= 6 month Favours usual care Favours treatment
